Chris Bower
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 15
-
- Antibiotic Use and Resistance 10
- Co-authors
- Neil V. Whittock (1 shared paper)Jesse T. Jacob (16 shared papers)Sarah W. Satola (5 shared papers)Ivan Bristow (1 shared paper)Jessica Howard‐Anderson (7 shared papers)Gillian Smith (5 shared papers)David S. Weiss (1 shared paper)Joseph D. Lutgring (4 shared papers)
- Journals
- Open Forum Infectious Diseases (8 papers)Infection Control and Hospital Epidemiology (5 papers)Clinical Infectious Diseases (1 paper)Clinical and Experimental Dermatology (1 paper)Microbiology Spectrum (1 paper)
- Partner nations
- United StatesUnited KingdomUganda
In The Last Decade
Chris Bower
18 papers receiving 103 citations
Peers
Comparison fields: 5 of 41
- Molecular Medicine 61
- Applied Microbiology and Biotechnology 23
- Endocrinology 14
- Clinical Biochemistry 17
- Pharmacology 21
Countries citing papers authored by Chris Bower
This map shows the geographic impact of Chris Bower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Bower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Bower more than expected).
Fields of papers citing papers by Chris Bower
This network shows the impact of papers produced by Chris Bower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Bower. The network helps show where Chris Bower may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Bower, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 26 | |
| 2 | 2021 | 22 | |
| 3 | 2021 | 11 | |
| 4 | 2016 | 9 | |
| 5 | 2022 | 7 | |
| 6 | 2019 | 7 | |
| 7 | 2020 | 5 | |
| 8 | 2021 | 4 | |
| 9 | 2017 | 3 | |
| 10 | 2021 | 2 | |
| 11 | 2016 | 2 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 1 | |
| 14 | 2013 | 1 | |
| 15 | 2019 | 1 | |
| 16 | 2016 | 1 | |
| 17 | 2018 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2020 | 0 | |
| 20 | 2020 | 0 |
About Chris Bower
Chris Bower is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Epidemiology, Clinical Biochemistry and Pharmacology, having authored 20 papers that have together received 105 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (15 papers), Antibiotic Use and Resistance (10 papers), Bacterial Identification and Susceptibility Testing (5 papers), Urinary Tract Infections Management (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Enterobacteriaceae and Cronobacter Research (3 papers), Pneumonia and Respiratory Infections (2 papers) and Cystic Fibrosis Research Advances (1 paper). The work is most often cited by research in Molecular Medicine (61 citations), Applied Microbiology and Biotechnology (23 citations), Endocrinology (14 citations), Clinical Biochemistry (17 citations) and Pharmacology (21 citations). Chris Bower has collaborated with scholars based in United States, United Kingdom and Uganda. Frequent co-authors include Neil V. Whittock, Jesse T. Jacob, Sarah W. Satola, Ivan Bristow, Jessica Howard‐Anderson, Gillian Smith, David S. Weiss, Joseph D. Lutgring, Max W. Adelman and Dan I. Andersson. Their work appears in journals such as Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology, Clinical Infectious Diseases, Clinical and Experimental Dermatology and Microbiology Spectrum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.